IGM BIOSCIENCES INC. news, videos and press releases
For more news please use our advanced search feature.
IGM BIOSCIENCES INC. - More news...
IGM BIOSCIENCES INC. - More news...
- IGM Biosciences Announces Refocusing of Sanofi Collaboration
- IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
- IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
- IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
- IGM Biosciences Announces Third Quarter 2023 Financial Results
- IGM Biosciences to Present at Two Upcoming Investor Conferences
- IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors
- IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
- IGM Biosciences Announces Second Quarter 2023 Financial Results
- IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement
- IGM Announces Proposed Public Offering and Concurrent Private Placement
- IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
- IGM Biosciences to Present at the Jefferies Healthcare Conference
- IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis
- IGM Biosciences to Host Conference Call and Webcast to Provide IGM-8444 Clinical Update
- IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at Two Upcoming Investor Conferences
- IGM Biosciences to Present at the Stifel 2023 Targeted Oncology Days
- IGM Biosciences Announces Six Presentations at the American Society for Cancer Research Annual Meeting 2023
- IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
- IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023
- IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference
- IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-7354 in Solid Tumors
- IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
- IGM Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
- IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting
- IGM Biosciences to Present at the Bank of America Biotech SMID Cap Conference